ABVC BIOPHARMA, INC.

Q: Jun 30 2026

Q: Mar 31 2026

Q: Mar 31 2026

Q: Sep 30 2025

FY: Dec 31 2025

Q: Sep 30 2025

Q: Jun 30 2025

Q: Mar 31 2025

FY: Dec 31 2024

FY: Dec 31 2024

Q: Sep 30 2024

Q: Jun 30 2024

Q: Mar 31 2024

Q: Mar 31 2024

FY: Dec 31 2023

FY: Dec 31 2023

Q: Sep 30 2023

Q: Sep 30 2023

Q: Jun 30 2023

Q: Mar 31 2023

Entry into a Material Definitive Agreement

Other Events

Other Events

Changes in Registrant's Certifying Accountant

Submission of Matters to a Vote of Security Holders

Results of Operations and Financial Condition

Unregistered Sales of Equity Securities

Results of Operations and Financial Condition

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Changes in Registrant's Certifying Accountant

Results of Operations and Financial Condition

Entry into a Material Definitive Agreement

Submission of Matters to a Vote of Security Holders

Unregistered Sales of Equity Securities

Unregistered Sales of Equity Securities

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review

Results of Operations and Financial Condition

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Prospectus Supplement with Pricing Information

Prospectus Supplement with Pricing Information

Prospectus Supplement with Pricing Information

Prospectus Supplement with Pricing Information

Post-effective amendment to a registration statement

Prospectus Supplement with Pricing Information

Prospectus Supplement with Pricing Information

Prospectus Supplement with Pricing Information

Prospectus Supplement with Pricing Information

Prospectus Supplement with Pricing Information

Prospectus Supplement with Pricing Information

Prospectus Supplement with Pricing Information

Prospectus Supplement with Pricing Information

Prospectus Supplement with Pricing Information

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Post-effective amendment to a registration statement

Post-effective amendment to a registration statement

Post-effective amendment to a registration statement

Registration statement under Securities Act of 1933

Notice of Effectiveness

Definitive Proxy Statement

No description available

No description available

No description available

Preliminary Proxy Statement

Definitive Proxy Statement

Preliminary Proxy Statement

Definitive Proxy Statement

Preliminary Proxy Statement

Preliminary Proxy Statement

Additional Information for Proxy Statement/ Votes

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Preliminary Proxy Statement

Definitive Proxy Statement

Preliminary Proxy Statement

Definitive Proxy Statement

Preliminary Proxy Statement

Definitive Proxy Statement

Definitive Proxy Statement

Lind Global Fund II LP

Jiang Eugene

Jiang Eugene

Lind Global Fund II LP

Lind Global Fund II LP

none

none

none

Jiang Shuling

An Chihliang

Sakamoto Norimi

Odaira Yoshinobu

Tseng Shih-Chen

Jiang Tsung Shann

Miao Shin-Yu

Jiang Chang-Jen

Jiang Eugene

Doong Howard

King Chi-Hsin Richard

Chou Yen-Hsin

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC